Envoy Medical appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance effective August 24, 2026. Mr. Potashnick receives a $315,000 annual base salary, a target bonus equal to 15% of base salary, and an initial equity award of 250,000 stock options at an exercise price of $0.746 per share. He previously served as the company's interim CFO on a contractor basis since June 2025. Envoy Medical develops and manufactures minimally invasive surgical devices for ear, nose, and throat procedures.
